Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.1.1 COMPETITIVE RIVALRY – HIGH
4.1.2 THREAT OF NEW ENTRANTS – MODERATE
4.1.3 BARGAINING POWER OF BUYERS – HIGH
4.1.4 BARGAINING POWER OF SUPPLIERS – MODERATE
4.1.5 THREAT OF SUBSTITUTES – MODERATE
4.2 PESTLE ANALYSIS
4.2.1 POLITICAL
4.2.2 ECONOMIC
4.2.3 SOCIAL
4.2.4 TECHNOLOGICAL
4.2.5 ENVIRONMENTAL
4.2.6 LEGAL
4.3 COST ANALYSIS BREAKDOWN
4.3.1 RESEARCH & DEVELOPMENT (R&D) COSTS (15–25%)
4.3.2 RAW MATERIAL AND COMPONENT COSTS (20–30%)
4.3.3 MANUFACTURING COSTS (15–20%)
4.3.4 REGULATORY & QUALITY COMPLIANCE (5–10%)
4.3.5 MARKETING & PROMOTION (10–15%)
4.3.6 DISTRIBUTION & LOGISTICS (5–10%)
4.3.7 LICENSING, ROYALTIES & IP MANAGEMENT (1–3%)
4.3.8 TRAINING, CLINICAL SUPPORT & AFTER-SALES (2–5%)
4.4 HEALTHCARE ECONOMY
4.4.1 HEALTHCARE EXPENDITURE
4.4.2 CAPITAL EXPENDITURE
4.4.3 CAPEX TRENDS
4.4.4 CAPEX ALLOCATION
4.4.5 FUNDING SOURCES
4.4.6 INDUSTRY BENCHMARKS
4.4.7 GDP RATIO IN OVERALL GDP
4.4.8 HEALTHCARE SYSTEM STRUCTURE
4.4.9 GOVERNMENT POLICIES
4.4.10 ECONOMIC DEVELOPMENT
4.5 OPPORTUNITY MAP ANALYSIS
4.5.1 OPPORTUNITY MAP ANALYSIS
4.5.2 PRODUCT INNOVATION
4.5.3 GEOGRAPHIC EXPANSION
4.5.4 CONSUMER SEGMENTATION
4.5.5 DELIVERY CHANNELS
4.5.6 REGULATORY & MARKET ACCESS
4.5.7 SUSTAINABILITY
4.6 INDUSTRY INSIGHTS
4.6.1 MICRO AND MACRO ECONOMIC FACTORS
4.6.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.6.3 KEY PRICING STRATEGIES
4.6.4 INTERVIEWS WITH SPECIALISTS
4.6.5 ANALYSIS AND RECOMMENDATION
4.7 PATENT ANALYSIS-
4.7.1 GEOGRAPHIC DISTRIBUTION OF PATENT FILINGS
4.7.2 KEY APPLICANTS AND INNOVATORS
4.7.3 TECHNOLOGICAL DOMAINS (IPC CODES)
4.8 PUBLICATION TRENDS OVER TIME
4.8.1 CONCLUSION
4.9 EIMBURSEMENT FRAMEWORK
4.9.1 COSMETIC VS. MEDICAL USE – THE CORE DIVIDER
4.9.2 REGIONAL REIMBURSEMENT VARIATIONS
4.9.3 OUT-OF-POCKET SPENDING DOMINANCE
4.9.4 TRENDS IN HYBRID INSURANCE MODELS
4.9.5 IMPLICATIONS FOR MARKET GROWTH
4.1 SUPPLY CHAIN ECOSYSTEM
4.11 TECHNOLOGY ROADMAP
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.12.1 INNOVATION TRACKER
4.12.1.1 Bio-Remodeling & Platform Technologies
4.12.1.2 Smart Filler Design & Volume Efficiency
4.12.1.3 Next-Generation Delivery Systems
4.12.1.4 Green Chemistry and Bioplastics
4.12.1.5 Combination Modalities
4.12.2 STRATEGIC ANALYSIS
4.12.2.1 M&A and Market Consolidation
4.12.2.2 Geographical Expansion & Localization Strategies
4.12.2.3 Regulatory Milestones
4.12.2.4 Marketing & Consumer Engagement
4.12.2.5 Strategic Partnerships & Distribution Rights
4.12.3 CONCLUSION
5 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS AND IMPORT VS. LOCAL PRODUCTION OUTLOOK
5.1 VENDOR SELECTION CRITERIA AND ITS IMPACT ON THE SUPPLY CHAIN
5.2 RAW MATERIAL PROCUREMENT, MANUFACTURING, AND DISTRIBUTION DYNAMICS
5.3 PRICE PITCHING AND COMPETITIVE POSITIONING IN THE MARKET
5.4 INDUSTRY RESPONSE: SUPPLY CHAIN OPTIMIZATION AND JOINT VENTURES
5.5 IMPACT OF REGULATORY FRAMEWORKS AND INCENTIVES ON PRICES
5.6 GEOPOLITICAL FACTORS AND TRADE AGREEMENTS SHAPING THE MARKET
5.7 INDUSTRIAL DEVELOPMENT SCHEMES AND INFRASTRUCTURE INITIATIVES
6 REGULATORY FRAMEWORK
6.1 NORTH AMERICA
6.1.1 REGULATORY AUTHORITIES:
6.1.2 REGULATORY CLASSIFICATIONS:
6.1.3 REGULATORY SUBMISSIONS:
6.1.4 INTERNATIONAL HARMONIZATION:
6.1.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:
6.2 SOUTH AMERICA
6.2.1 REGULATORY AUTHORITIES:
6.2.2 REGULATORY CLASSIFICATIONS:
6.2.3 REGULATORY SUBMISSIONS:
6.2.4 INTERNATIONAL HARMONIZATION:
6.2.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:
6.2.6 REGULATORY CHALLENGES AND STRATEGIES:
6.3 EUROPE
6.3.1 REGULATORY AUTHORITIES:
6.3.2 REGULATORY CLASSIFICATIONS:
6.3.3 REGULATORY SUBMISSIONS:
6.3.4 INTERNATIONAL HARMONIZATION:
6.3.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:
6.3.6 REGULATORY CHALLENGES AND STRATEGIES:
6.4 ASIA-PACIFIC
6.4.1 REGULATORY AUTHORITIES:
6.4.2 REGULATORY CLASSIFICATIONS:
6.4.3 REGULATORY SUBMISSIONS:
6.4.4 INTERNATIONAL HARMONIZATION:
6.4.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:
6.4.6 REGULATORY CHALLENGES AND STRATEGIES:
6.5 MIDDLE EAST AND AFRICA
6.5.1 REGULATORY AUTHORITIES:
6.5.2 REGULATORY CLASSIFICATIONS:
6.5.3 REGULATORY SUBMISSIONS:
6.5.4 INTERNATIONAL HARMONIZATION:
6.5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:
6.5.6 REGULATORY CHALLENGES AND STRATEGIES:
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING DEMAND FOR MINIMALLY INVASIVE COSMETIC PROCEDURES
7.1.2 RISING INFLUENCE OF SOCIAL MEDIA AND CELEBRITY CULTURE
7.1.3 INCREASING ACCEPTANCE OF COSMETIC ENHANCEMENTS AMONG MILLENNIALS AND GEN Z
7.1.4 RISING POPULARITY OF COMBINATION TREATMENTS
7.2 RESTRAINTS
7.2.1 HIGH COST OF AESTHETIC INJECTABLE PROCEDURES
7.2.2 SHORT-TERM EFFECTIVENESS OF CERTAIN FILLERS
7.3 OPPORTUNITIES
7.3.1 EXPANSION IN EMERGING MARKETS
7.3.2 PRODUCT INNOVATION AND PERSONALIZED SOLUTIONS
7.3.3 BROADENING INTO ADDITIONAL THERAPEUTIC AREAS
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS IN CERTAIN REGIONS
7.4.2 COUNTERFEIT AND UNREGULATED PRODUCTS
8 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE
8.1 OVERVIEW
8.2 BIODEGRADABLE AESTHETIC INJECTABLE FILLERS
8.2.1 TEMPORARY BIODEGRADABLE
8.2.2 SEMI-PERMANENT BIODEGRADABLE
8.3 NON-BIODEGRADABLE AESTHETIC INJECTABLE FILLERS
9 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 NATURAL AESTHETIC INJECTABLE FILLERS
9.2.1 HYALURONIC ACID (HA)
9.2.1.1 MONOPHASIC FILLERS
9.2.1.1.1 HYALURONIC ACID + LIDOCAINE
9.2.1.1.2 MONODENSIFIED
9.2.1.1.3 POLYDENSIFIES
9.2.1.1.4 FACIAL LINE CORRECTION
9.2.1.1.5 LIP ENHANCEMENT
9.2.1.1.6 FACE LIFT
9.2.1.1.7 RHINOPLASTY
9.2.1.1.8 SCAR TREATMENT
9.2.1.1.9 SAGGING SKIN
9.2.1.1.10 CHEEK DEPRESSION
9.2.1.1.11 DENTISTRY
9.2.1.1.12 RECONSTRUCTIVE SURGERY
9.2.1.1.13 AESTHETIC RESTORATION
9.2.1.1.14 CHIN AUGMENTATION
9.2.1.1.15 LIPOATROPHY TREATMENT
9.2.1.1.16 SKIN SMOOTHING
9.2.1.1.17 EARLOBE REJUVENATION
9.2.1.1.18 OTHERS.
9.2.1.2 BIPHASIC FILLERS
9.2.1.2.1 HYALURONIC ACID + LIDOCAINE
9.2.1.2.2 SINGLE-PHASE
9.2.1.2.3 DUPLEX-PHASE
9.2.1.2.4 FACIAL LINE CORRECTION
9.2.1.2.5 LIP ENHANCEMENT
9.2.1.2.6 FACE LIFT
9.2.1.2.7 RHINOPLASTY
9.2.1.2.8 SCAR TREATMENT
9.2.1.2.9 SAGGING SKIN
9.2.1.2.10 CHEEK DEPRESSION
9.2.1.2.11 DENTISTRY
9.2.1.2.12 RECONSTRUCTIVE SURGERY
9.2.1.2.13 AESTHETIC RESTORATION
9.2.1.2.14 CHIN AUGMENTATION
9.2.1.2.15 LIPOATROPHY TREATMENT
9.2.1.2.16 SKIN SMOOTHING
9.2.1.2.17 EARLOBE REJUVENATION
9.2.1.2.18 OTHERS
9.2.2 FAT
9.2.2.1 FACIAL LINE CORRECTION
9.2.2.2 LIP ENHANCEMENT
9.2.2.3 FACE LIFT
9.2.2.4 RHINOPLASTY
9.2.2.5 SCAR TREATMENT
9.2.2.6 SAGGING SKIN
9.2.2.7 CHEEK DEPRESSION
9.2.2.8 RECONSTRUCTIVE SURGERY
9.2.2.9 DENTISTRY
9.2.2.10 AESTHETIC RESTORATION
9.2.2.11 LIPOATROPHY TREATMENT
9.2.2.12 CHIN AUGMENTATION
9.2.2.13 SKIN SMOOTHING
9.2.2.14 EARLOBE REJUVENATION
9.2.2.15 OTHERS
9.2.3 COLLAGEN
9.2.3.1 FACIAL LINE CORRECTION
9.2.3.2 LIP ENHANCEMENT
9.2.3.3 FACE LIFT
9.2.3.4 RHINOPLASTY
9.2.3.5 SCAR TREATMENT
9.2.3.6 SAGGING SKIN
9.2.3.7 CHEEK DEPRESSION
9.2.3.8 RECONSTRUCTIVE SURGERY
9.2.3.9 AESTHETIC RESTORATION
9.2.3.10 CHIN AUGMENTATION
9.2.3.11 DENTISTRY
9.2.3.12 LIPOATROPHY TREATMENT
9.2.3.13 SKIN SMOOTHING
9.2.3.14 EARLOBE REJUVENATION
9.2.3.15 OTHERS
9.2.4 POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN)
9.2.4.1 FACIAL LINE CORRECTION
9.2.4.2 LIP ENHANCEMENT
9.2.4.3 FACE LIFT
9.2.4.4 RHINOPLASTY
9.2.4.5 SCAR TREATMENT
9.2.4.6 SAGGING SKIN
9.2.4.7 CHEEK DEPRESSION
9.2.4.8 AESTHETIC RESTORATION
9.2.4.9 RECONSTRUCTIVE SURGERY
9.2.4.10 DENTISTRY
9.2.4.11 CHIN AUGMENTATION
9.2.4.12 LIPOATROPHY TREATMENT
9.2.4.13 SKIN SMOOTHING
9.2.4.14 EARLOBE REJUVENATION
9.2.4.15 OTHERS
9.2.5 OTHERS
9.2.5.1 FACIAL LINE CORRECTION
9.2.5.2 LIP ENHANCEMENT
9.2.5.3 FACE LIFT
9.2.5.4 RHINOPLASTY
9.2.5.5 SCAR TREATMENT
9.2.5.6 SAGGING SKIN
9.2.5.7 CHEEK DEPRESSION
9.2.5.8 RECONSTRUCTIVE SURGERY
9.2.5.9 AESTHETIC RESTORATION
9.2.5.10 DENTISTRY
9.2.5.11 CHIN AUGMENTATION
9.2.5.12 LIPOATROPHY TREATMENT
9.2.5.13 SKIN SMOOTHING
9.2.5.14 EARLOBE REJUVENATION
9.2.5.15 OTHERS
9.3 SYNTHETIC AESTHETIC INJECTABLE FILLERS
9.3.1 CALCIUM HYDROXYLAPATITE (CAHA)
9.3.1.1 FACIAL LINE CORRECTION
9.3.1.2 LIP ENHANCEMENT
9.3.1.3 FACE LIFT
9.3.1.4 RHINOPLASTY
9.3.1.5 SCAR TREATMENT
9.3.1.6 SAGGING SKIN
9.3.1.7 CHEEK DEPRESSION
9.3.1.8 RECONSTRUCTIVE SURGERY
9.3.1.9 AESTHETIC RESTORATION
9.3.1.10 DENTISTRY
9.3.1.11 CHIN AUGMENTATION
9.3.1.12 LIPOATROPHY TREATMENT
9.3.1.13 SKIN SMOOTHING
9.3.1.14 EARLOBE REJUVENATION
9.3.1.15 OTHERS
9.3.2 POLY-L-LACTIC ACID (PLLA)
9.3.2.1 FACIAL LINE CORRECTION
9.3.2.2 LIP ENHANCEMENT
9.3.2.3 FACE LIFT
9.3.2.4 RHINOPLASTY
9.3.2.5 SCAR TREATMENT
9.3.2.6 SAGGING SKIN
9.3.2.7 CHEEK DEPRESSION
9.3.2.8 RECONSTRUCTIVE SURGERY
9.3.2.9 AESTHETIC RESTORATION
9.3.2.10 DENTISTRY
9.3.2.11 CHIN AUGMENTATION
9.3.2.12 LIPOATROPHY TREATMENT
9.3.2.13 SKIN SMOOTHING
9.3.2.14 EARLOBE REJUVENATION
9.3.2.15 OTHERS
9.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
9.3.3.1 FACIAL LINE CORRECTION
9.3.3.2 LIP ENHANCEMENT
9.3.3.3 FACE LIFT
9.3.3.4 RHINOPLASTY
9.3.3.5 SCAR TREATMENT
9.3.3.6 SAGGING SKIN
9.3.3.7 CHEEK DEPRESSION
9.3.3.8 RECONSTRUCTIVE SURGERY
9.3.3.9 AESTHETIC RESTORATION
9.3.3.10 DENTISTRY
9.3.3.11 CHIN AUGMENTATION
9.3.3.12 LIPOATROPHY TREATMENT
9.3.3.13 SKIN SMOOTHING
9.3.3.14 EARLOBE REJUVENATION
9.3.3.15 OTHERS
10 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 BRANDED
10.2.1 JUVEDERM
10.2.2 RESTYLANE
10.2.3 RADIESSE
10.2.4 SCULPTRA
10.2.5 ELLANSE
10.2.6 BELLAFILL
10.2.7 AQUAMID
10.2.8 ELEVESS
10.2.9 OTHERS
10.3 GENERIC
11 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 FACIAL LINE CORRECTION
11.2.1 DYNAMIC WRINKLES
11.2.2 STATIC WRINKLES
11.2.3 WRINKLE FOLDS
11.2.4 LAUGH LINES
11.2.5 FOREHEAD LINES
11.2.6 WORRY LINES
11.2.7 CROW’S FEET
11.2.8 LIP LINES
11.2.9 MARIONETTE LINES
11.2.10 PUPPET WRINKLES
11.2.11 BUNNY LINES
11.2.12 OTHERS
11.2.13 JUVEDERM
11.2.14 RESTYLANE
11.2.15 BELOTERO
11.2.16 RADIESSE
11.2.17 OTHERS
11.3 LIP ENHANCEMENT
11.3.1 JUVÉDERM
11.3.1.1 JUVÉDERM XC
11.3.1.2 VOLUMA
11.3.1.3 VOLBELLA
11.3.1.4 VOLLURE
11.3.2 RESTYLANE
11.3.2.1 RESTYLANE LYFT
11.3.2.2 RESTYLANE KYSSE
11.3.2.3 RESTYLANE CONTOUR
11.3.2.4 RESTYLANE REFYNE
11.3.2.5 RESTYLANE SILK
11.3.3 BELOTERO BALANCE
11.3.4 RHA
11.3.4.1 RHA 2
11.3.4.2 RHA 3
11.3.4.3 RHA 4
11.3.5 REVANESSE VERSA
11.3.6 HYLAFORM
11.3.7 ELEVESS
11.3.8 PREVELLE SILK
11.3.9 OTHERS
11.4 FACE LIFT
11.4.1 DEEP PLANE/SMAS FACELIFT
11.4.2 MINI FACELIFT
11.4.3 MID-FACELIFT
11.4.4 LIQUID FACELIFT
11.4.5 CHEEK LIFT
11.4.6 JAW LINE REJUVENATION
11.4.7 S-LIFT
11.4.8 CUTANEOUS LIFT
11.4.9 TEMPORAL/BROW LIFT
11.4.10 OTHERS
11.4.11 JUVEDERM
11.4.12 RESTYLANE
11.4.13 SCULPTRA
11.4.14 DYSPORT
11.4.15 OTHERS
11.5 RHINOPLASTY
11.5.1 JUVÉDERM
11.5.1.1 VOLUMA
11.5.1.2 VOLBELLA
11.5.1.3 JUVÉDERM XC
11.5.1.4 VOLLURE
11.5.2 RESTYLANE
11.5.2.1 RESTYLANE LYFT
11.5.2.2 RESTYLANE SILK
11.5.2.3 RESTYLANE REFYNE
11.5.2.4 RESTYLANE KYSSE
11.5.2.5 RESTYLANE CONTOUR
11.5.3 BELOTERO BALANCE
11.5.4 REVANESSE VERSA
11.5.5 RHA
11.5.5.1 RHA 2
11.5.5.2 RHA 3
11.5.5.3 RHA 4
11.5.6 HYLAFORM
11.5.7 ELEVESS
11.5.8 PREVELLE SILK
11.5.9 OTHERS
11.6 SCAR TREATMENT
11.6.1 ACNE SCARS
11.6.2 HYPERTROPHIC SCARS
11.6.3 KELOID SCARS
11.6.4 CONTRACTURE SCARS
11.6.5 OTHERS
11.6.6 JUVEDERM
11.6.7 RESTYLANE
11.6.8 RADIESSE
11.6.9 BELOTERO
11.6.10 PERLANE
11.6.11 OTHERS
11.7 SAGGING SKIN
11.7.1 BOLETERO
11.7.2 RESTYLANE
11.7.3 JUVEDERM
11.7.4 OTHERS
11.8 CHEEK DEPRESSION
11.8.1 JUVEDERM VOLUMA
11.8.2 RESTYLANE-LYFT
11.8.3 SCULPTRA
11.8.4 RADIESSE
11.8.5 OTHERS
11.9 RECONSTRUCTIVE SURGERY
11.9.1 JUVEDERM
11.9.2 RESTYLANE
11.9.3 OTHERS
11.1 AESTHETIC RESTORATION
11.10.1 JUVÉDERM
11.10.1.1 JUVEDERM ULTRA XC
11.10.1.2 JUVEDERM VOLBELLA XC
11.10.1.3 JUVEDERM VOLLURE XC
11.10.2 RESTYLANE
11.10.2.1 RESTYLANE LYFT
11.10.2.2 RESTYLANE-L
11.10.2.3 RESTYLANE REFYNE AND DEFYNE
11.10.2.4 RESTYLANE SILK
11.10.3 SCULPTRA
11.10.4 RADIESSE
11.10.5 RHA
11.10.5.1 RHA 2
11.10.5.2 RHA 3
11.10.5.3 RHA 4
11.10.6 REVANESSE VERSA
11.10.7 BELOTERO BALANCE
11.10.8 BELLAFILL
11.10.9 OTHERS
11.11 DENTISTRY
11.11.1 JUVEDERM
11.11.2 RESTYLANE
11.11.3 RADIESSE
11.11.4 OTHERS
11.12 CHIN AUGMENTATION
11.12.1 JUVEDERM VOLUMA XC
11.12.2 RESTYLANE DEFYNE
11.12.3 OTHERS
11.13 LIPOATROPHY TREATMENT
11.13.1 SCULPTRA
11.13.2 OTHERS
11.14 SKIN SMOOTHING
11.14.1 RESTYLANE
11.14.2 BELOTERO
11.14.3 BELLAFIL
11.14.4 OTHERS
11.15 EARLOBE REJUVENATION
11.15.1 SCULPTRA
11.15.2 RESTYLANE
11.15.3 ELLANSÉ
11.15.4 BELOTERO
11.15.5 JUVEDERM
11.15.6 OTHERS
11.16 OTHERS
12 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER
12.1 OVERVIEW
12.2 DERMATOLOGY CLINICS
12.3 HOSPITALS
12.4 AMBULATORY SURGICAL CENTERS
12.5 OTHERS
13 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER/DIRECT DISTRIBUTION
13.3 DRUG STORES
13.4 ONLINE PHARMACY
13.5 OTHERS
14 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
15 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ALLERGAN AESTHETICS
17.1.1 COMPANY SNAPSHOTS
17.1.2 REVENUE ANALYSIS AND SEGMENTED ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 GALDERMA
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 MERZ PHARMA
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 HUGEL, INC.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 LG CHEM
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AMALIAN
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 BIOSCIENCE
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 BIOPLUS CO. LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIOXIS PHARMACEUTICALS
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 CONTURA INTERNATIONAL LTD
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 CROMA-PHARMA GMBH
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 HUONS GLOBAL
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENT
17.13 HUMEDIX
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 IBSA INSTITUT BIOCHIMIQUE SA
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 JALUPRO
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LABORATORIES VIVACY
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 LABORATORIES FILLMED
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 MEDYTOX INC
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 MESOESTETIC
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 PETRONE GROUP
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 PREMIER MEDICAL GROUP
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 PROLLENIUM MEDICAL TECHNOLOGIES
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 REVANCE
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 SINCLAIR
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 SHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
17.26 SOSUM GLOBAL
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENT
17.27 TIGER AESTHETICS MEDICAL, LLC
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENT
17.28 TEOXANE
17.28.1 COMPANY SNAPSHOT
17.28.2 PRODUCT PORTFOLIO
17.28.3 RECENT DEVELOPMENT
17.29 VIDA SRL.
17.29.1 COMPANY SNAPSHOT
17.29.2 PRODUCT PORTFOLIO
17.29.3 RECENT DEVELOPMENT
17.3 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD.
17.30.1 COMPANY SNAPSHOT
17.30.2 PRODUCT PORTFOLIO
17.30.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 2 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 3 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 4 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 5 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 6 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 7 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 8 NORTH AMERICA NON-BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 9 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)
TABLE 10 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 11 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 12 NORTH AMERICA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 13 NORTH AMERICA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 14 NORTH AMERICA HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 15 NORTH AMERICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 16 NORTH AMERICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 17 NORTH AMERICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)
TABLE 18 NORTH AMERICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 19 NORTH AMERICA FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 20 NORTH AMERICA COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 21 NORTH AMERICA POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 22 NORTH AMERICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 23 NORTH AMERICA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 24 NORTH AMERICA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 25 NORTH AMERICA CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 26 NORTH AMERICA POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 27 NORTH AMERICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 28 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)
TABLE 29 NORTH AMERICA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 30 NORTH AMERICA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 31 NORTH AMERICA GENERIC IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 32 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 33 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 34 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 35 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)
TABLE 36 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 37 NORTH AMERICA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 38 NORTH AMERICA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 39 NORTH AMERICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 40 NORTH AMERICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 41 NORTH AMERICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 42 NORTH AMERICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 43 NORTH AMERICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 44 NORTH AMERICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 45 NORTH AMERICA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 46 NORTH AMERICA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 47 NORTH AMERICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 48 NORTH AMERICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 49 NORTH AMERICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 50 NORTH AMERICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 51 NORTH AMERICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 52 NORTH AMERICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 53 NORTH AMERICA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 54 NORTH AMERICA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 55 NORTH AMERICA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 56 NORTH AMERICA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 57 NORTH AMERICA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 58 NORTH AMERICA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 59 NORTH AMERICA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 60 GNORTH AMERICA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 61 NORTH AMERICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 62 NORTH AMERICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 63 NORTH AMERICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 64 NORTH AMERICA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 65 NORTH AMERICA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 66 NORTH AMERICA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 67 NORTH AMERICA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 68 NORTH AMERICA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 69 NORTH AMERICA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 70 NORTH AMERICA SKIN SMOOTHING IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 71 NORTH AMERICA SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 72 NORTH AMERICA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 73 NORTH AMERICA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 74 NORTH AMERICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 75 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)
TABLE 76 NORTH AMERICA DERMATOLOGY CLINICS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 77 NORTH AMERICA HOSPITALS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 78 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 79 NORTH AMERICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 80 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)
TABLE 81 NORTH AMERICA DIRECT TENDER/DIRECT DISTRIBUTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 82 NORTH AMERICA DRUG STORES IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 83 NORTH AMERICA ONLINE PHARMACY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 84 NORTH AMERICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)
TABLE 85 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY COUNTRY, 2018-2036 (USD THOUSAND)
TABLE 86 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)
TABLE 87 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 88 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 89 NORTH AMERICA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 90 NORTH AMERICA HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 91 NORTH AMERICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 92 NORTH AMERICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 93 NORTH AMERICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)
TABLE 94 NORTH AMERICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 95 NORTH AMERICA FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 96 NORTH AMERICA COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 97 NORTH AMERICA POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 98 NORTH AMERICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 99 NORTH AMERICA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 100 NORTH AMERICA CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 101 NORTH AMERICA POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 102 NORTH AMERICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 103 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 104 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 105 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 106 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 107 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 108 NORTH AMERICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 109 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 110 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 111 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)
TABLE 112 NORTH AMERICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 113 NORTH AMERICA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 114 NORTH AMERICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 115 NORTH AMERICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 116 NORTH AMERICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 117 NORTH AMERICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 118 NORTH AMERICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 119 NORTH AMERICA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 120 NORTH AMERICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 121 NORTH AMERICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 122 NORTH AMERICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 123 NORTH AMERICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 124 NORTH AMERICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 125 NORTH AMERICA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 126 NORTH AMERICA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 127 NORTH AMERICA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 128 NORTH AMERICA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 129 NORTH AMERICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 130 NORTH AMERICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 131 NORTH AMERICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 132 NORTH AMERICA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 133 NORTH AMERICA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 134 NORTH AMERICA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 135 NORTH AMERICA SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 136 NORTH AMERICA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 137 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)
TABLE 138 NORTH AMERICA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 139 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)
TABLE 140 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)
TABLE 141 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)
TABLE 142 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 143 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 144 U.S. NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 145 U.S. HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 146 U.S. MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 147 U.S. MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 148 U.S. BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)
TABLE 149 U.S. BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 150 U.S. FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 151 U.S. COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 152 U.S. POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 153 U.S. OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 154 U.S. SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 155 U.S. CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 156 U.S. POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 157 U.S. POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 158 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 159 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 160 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 161 U.S. BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 162 U.S. BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 163 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 164 U.S. FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 165 U.S. FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)
TABLE 166 U.S. FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 167 U.S. LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 168 U.S. JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 169 U.S. RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 170 U.S. RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 171 U.S. FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 172 U.S. FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 173 U.S. RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 174 U.S. JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 175 U.S. RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 176 U.S. RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 177 U.S. SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 178 U.S. SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 179 U.S. SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 180 U.S. CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 181 U.S. RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 182 U.S. AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 183 U.S. JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 184 U.S. RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 185 U.S. RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 186 U.S. DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 187 U.S. CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 188 U.S. LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 189 U.S. SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 190 U.S. EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 191 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)
TABLE 192 U.S. BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 193 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)
TABLE 194 U.S. AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)
TABLE 195 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)
TABLE 196 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 197 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 198 CANADA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 199 CANADA HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 200 CANADA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 201 CANADA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 202 CANADA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)
TABLE 203 CANADA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 204 CANADA FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 205 CANADA COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 206 CANADA POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 207 CANADA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 208 CANADA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 209 CANADA CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 210 CANADA POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 211 CANADA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 212 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 213 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 214 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 215 CANADA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 216 CANADA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)
TABLE 217 CANADA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)
TABLE 218 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)
TABLE 219 CANADA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 220 CANADA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)
TABLE 221 CANADA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 222 CANADA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 223 CANADA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 224 CANADA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 225 CANADA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 226 CANADA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 227 CANADA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 228 CANADA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 229 CANADA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 230 CANADA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 231 CANADA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 232 CANADA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 233 CANADA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)
TABLE 234 CANADA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 235 CANADA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 236 CANADA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 237 CANADA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 238 CANADA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 239 CANADA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 240 CANADA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 241 CANADA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 242 CANADA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 243 CANADA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 244 CANADA SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 245 CANADA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 246 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)
TABLE 247 CANADA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)
TABLE 248 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)
TABLE 249 CANADA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: NORTH AMERICA VS REGIONAL ANALYSIS
FIGURE 5 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: EXECUTIVE SUMMARY
FIGURE 11 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: SEGMENTATION
FIGURE 12 TWO SEGMENTS COMPRISE THE NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 GROWING DEMAND FOR MINIMALLY INVASIVE COSMETIC PROCEDURES EXPECTED TO DRIVE THE NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET IN THE FORECAST PERIOD OF 2025 TO 2036
FIGURE 15 NATURAL AESTHETIC INJECTABLE FILLERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET IN 2025 & 2036
FIGURE 16 PORTER’S FIVE FORCES
FIGURE 17 PATENT FILINGS ACROSS SEVERAL KEY JURISDICTIONS:
FIGURE 18 KEY APPLICANTS V/S NUMBER OF PATENTS.
FIGURE 19 IPC CODES V/S PATENT COUNT.
FIGURE 20 YEAR V/S NUMBER OF PATENTS PUBLISHED
FIGURE 21 DROC ANALYSIS
FIGURE 22 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, 2024
FIGURE 23 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, 2025 TO 2036 (USD THOUSAND)
FIGURE 24 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, CAGR (2025- 2036)
FIGURE 25 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, 2024
FIGURE 27 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, 2025 TO 2036 (USD THOUSAND)
FIGURE 28 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, CAGR (2025- 2036)
FIGURE 29 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, 2024
FIGURE 31 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, 2025 TO 2036 (USD THOUSAND)
FIGURE 32 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, CAGR (2025- 2036)
FIGURE 33 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 34 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, 2024
FIGURE 35 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, 2025 TO 2036 (USD THOUSAND)
FIGURE 36 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, CAGR (2025- 2036)
FIGURE 37 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, 2024
FIGURE 39 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, 2025 TO 2036 (USD THOUSAND)
FIGURE 40 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, CAGR (2025- 2036)
FIGURE 41 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 43 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2036 (USD THOUSAND)
FIGURE 44 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2036)
FIGURE 45 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: SNAPSHOT (2024)
FIGURE 47 NORTH AMERICA AESTHETIC INJECTABLE FILLERS MARKET: COMPANY SHARE 2024 (%)
